One licence covers screening, clinician-entered cardiac measurement records, assessments, session records, adverse event logging and follow-up scheduling. The full Medication & Psychedelic Readiness system is included in every tier — never an add-on. Prices exclude GST/VAT.
The structured safety layer that closes the biggest gap in psychedelic care: patients arriving on antidepressants or other medicines without documented screening. It is part of the core licence on Practitioner, Clinic and Network alike — not an upgrade, not an add-on module.
Documentation, education and clinical record support only. The platform does not acquire patient data, monitor patients, diagnose, prescribe or alter medicines. Any medicine decision belongs to the patient’s prescribing clinician.
Licensed outside New Zealand, your organisation sets its own country, timezone, locale, currency, unit system (metric or imperial) and the regulatory statement shown to clinicians and patients. Billing can be issued in your local currency.
Yes. Treatment Companion App is notified in Medsafe's WAND database as a Class I medical device. WAND notification does not constitute Medsafe approval or endorsement. It is a documentation and clinical record-support tool. Clinicians measure with separate equipment and enter the readings. It does not acquire data, monitor patients, diagnose, interpret ECG traces, prescribe or alter medicines. Fixed built-in threshold prompts require clinician review and do not replace clinical judgement, cardiac telemetry or other monitoring equipment.
Yes. Country, timezone, locale, currency, units and the regulatory wording shown to users are configuration. The clinical core, protocols and thresholds are the same everywhere.
Any tier can be trialled, and you can switch the tier you are trialling at any time in Settings → Licence — seats and limits update immediately. The trial runs 21 days with full functionality. If a licence is not activated, the account becomes read-only — records are retained, not deleted.
No. The Medication & Psychedelic Readiness system — medication inventory, substance-specific interaction screening, cardiac and antidepressant readiness, the 11-stage workflow, prescriber decisions, clinical report and audit trail — is included in every tier, including Practitioner.
Never. It is an educational and clinical-support system. Every screen states that medication changes are planned and managed only by the patient's prescribing clinician, and flags are presented as prompts for clinician review with cited evidence.
Your organisation. Records are scoped by row-level access control: patients can read only their own record, and clinical staff only records within your organisation.